Brain Tumor Therapeutics Market Analysis and Forecasts 2018 – 2023

The global brain tumor therapeutics market has been estimated to reach USD 2.74 billion in 2023. The market is expected to register a CAGR of 11% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements. Developed healthcare infrastructure, greater per capita healthcare spending, and comparatively higher awareness regarding advanced technologies are other impact rendering factors.

Get a PDF Sample of this Report @ http://orbisresearch.com/contacts/request-sample/2126810?utm_source=shreyas

Increasing incidence of brain cancer and focus on precision medicine
Increasing incidence of Brain Cancer has resulted in upsurge the demand for brain cancer across the globe which is driving the market. In addition, increased focus on precision medicine is also fuelling the global brain tumor therapeutics market.

Few brain cancer specific drugs and high cost of treatment
Few brain cancer specific drugs and their high cost is acting as a restraint for Brain Tumor therapeutics market. Although various pharmaceutical companies are spending heavily on R&D activities which can bring more treatment options to the market in future.

North America to Dominate the Market
The Brain Tumor Therapeutics market is segmented by type of treatment and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. North America dominates the Brain Tumor therapeutics market due to the increasing technological advancements and the rising incidence of brain cancer in the country. Asia-Pacific is also expected to propel the Brain Tumor therapeutics market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing geriatric population.

Key developments in the market
In January, 2018 iTeos Therapeutics has regained rights to its Phase 1 brain cancer drug from Pfizer, and plans to continue oncology development.
In December, 2017, Diffusion Pharmaceuticals (DFFN) Launches Phase 3 Trial for Glioblastoma

Major key players: F. HOFFMAN LA-ROCHE LTD., MERCK, NOVARTIS, IMMUNOCELLULAR THERAPEUTICS, NOVOCURE, DELMAR PHARMACEUTICALS INC. MOLECULIN BIOTECH etc.

Enquiry before buying report @ http://orbisresearch.com/contacts/enquiry-before-buying/2126810?utm_source=shreyas

Reasons to purchase this report
Market analysis for the Global Brain Tumor Therapeutics Market, with region-specific assessments and competition analysis on a global and regional scale.
Analyzing various perspectives of the company with the help of Porter’s five forces analysis
The treatment type that is expected to dominate the market
Regions that are expected to witness fastest growth during the forecast period
Identify the latest developments, market shares and strategies employed by the major market players.
3 months analyst support along with the Market Estimate sheet in excel.

Customization of the report
This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Access the complete report with TOC & List of Tables @ http://www.orbisresearch.com/reports/index/global-brain-tumor-therapeutics-market-growth-trends-and-forecasts-2018-2023?utm_source=shreyas

Companies Mentioned:
NOVARTIS,
F. HOFFMAN LA-ROCHE LTD.,
MERCK & CO., INC.,
IMMUNOCELLULAR THERAPEUTICS LTD.,
NOVOCURE,
DEL MAR PHARMACEUTICALS INC.,
MOLECULIN BIOTECH

Table of Content

INTRODUCTION
1.1 MARKET DEFINITION
RESEARCH METHODOLOGY
EXECUTIVE SUMMARY
KEY INFERENCES
MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING ADOPTION OF STEM CELL TECHNOLOGY
6.1.2 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.3 EMERGING APPLICATIONS OF GENE THERAPY IN REGENERATIVE MEDICINE
6.1.4 TECHNOLOGICAL ADVANCES IN REGENERATIVE MEDICINE (STEM CELL, TISSUE ENGINEERING, AND NANOTECHNOLOGY)
6.1.5 HIGH INVESTMENT & FUNDING TO SUPPORT DEVELOPMENT OF RM
6.2 MARKET RESTRAINTS
6.2.1 HIGH COST OF TREATMENT AND LESS AWARENESS
6.2.2 REGULATORY AND ETHICAL ISSUES PERTAINING STEM CELL, TISSUES ENGINEERING AND REGENERATIVE MEDICINE
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
MARKET SEGMENTATION
7.1 BY PRODUCT
7.1.1 CELL-BASED PRODUCTS
7.1.1.1 ALLOGENEIC PRODUCTS
7.1.1.2 AUTOLOGOUS PRODUCTS
7.1.2 ACELLULAR PRODUCTS
7.2 BY THERAPY
7.2.1 CELL THERAPY
7.2.2 TISSUE ENGINEERING
7.2.3 IMMUNOTHERAPY
7.2.4 GENE THERAPY
7.3 BY APPLICATION
7.3.1 ORTHOPEDIC & MUSCULOSKELETAL DISORDERS
7.3.2 DERMATOLOGY
7.3.3 CARDIOLOGY
7.3.4 CENTRAL NERVOUS SYSTEM DISEASES
7.3.5 ONCOLOGY
7.3.6 DIABETES
7.3.7 OTHERS
7.4 BY GEOGRAPHY
7.4.1 NORTH AMERICA
7.4.1.1 US
7.4.1.2 CANADA
7.4.1.3 MEXICO
7.4.2 EUROPE
7.4.2.1 FRANCE
7.4.2.2 UK
7.4.2.3 GERMANY
7.4.2.4 ITALY
7.4.2.5 SPAIN
7.4.2.6 REST OF EUROPE
7.4.3 ASIA-PACIFIC
7.4.3.1 INDIA
7.4.3.2 CHINA
7.4.3.3 JAPAN
7.4.3.4 AUSTRALIA
7.4.3.5 SOUTH KOREA
7.4.3.6 REST OF APAC
7.4.4 MIDDLE EAST AND AFRICA
7.4.4.1 GCC
7.4.4.2 SOUTH AFRICA
7.4.4.3 REST OF MIDDLE EAST AND AFRICA
7.4.5 SOUTH AMERICA
7.4.5.1 BRAZIL
7.4.5.2 ARGENTINA
7.4.5.3 REST OF SOUTH AMERICA
COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
KEY PLAYERS
9.1 NOVARTIS
9.2 F. HOFFMAN LA-ROCHE LTD.
9.3 MERCK & CO., INC.
9.4 IMMUNOCELLULAR THERAPEUTICS, LTD.
9.5 NOVOCURE
9.6 DEL MAR PHARMACEUTICALS INC.
9.7 MOLECULIN BIOTECH
9.8 OTHERS
FUTURE OUTLOOK OF THE MARKET

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Posted by Rahul Jadhav on Friday May 11 2018, 5:46 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0